Renaissance Technologies (RenTech)'s OPRX Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 216,856 shares of OptimizeRx Corporation (OPRX) worth $1.36 M, representing 0.00% of the portfolio. First purchased in 2019-Q2, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in OPRX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 187,278 shares. Largest reduction occurred in Q2 2023, reducing 120,900 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s OptimizeRx Corporation (OPRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly OptimizeRx Corporation (OPRX) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +187,278 | Add 633.17% | 216,856 | $6.28 |
| Q4 2025 | -78,322 | Reduce 72.59% | 29,578 | $12.26 |
| Q3 2025 | +30,193 | Add 38.85% | 107,900 | $20.50 |
| Q2 2025 | +77,707 | New Buy | 77,707 | $13.50 |
| Q4 2024 | -67,500 | Sold Out | 0 | $0.00 |
| Q3 2024 | -74,646 | Reduce 52.51% | 67,500 | $7.72 |
| Q2 2024 | +71,700 | Add 101.78% | 142,146 | $10.00 |
| Q1 2024 | -21,899 | Reduce 23.71% | 70,446 | $12.15 |
| Q4 2023 | +92,345 | New Buy | 92,345 | $14.31 |
| Q3 2023 | -63,500 | Sold Out | 0 | $0.00 |
| Q2 2023 | -120,900 | Reduce 65.56% | 63,500 | $0.01 |
| Q1 2023 | +143,417 | Add 349.94% | 184,400 | $0.01 |
| Q4 2022 | +8,783 | Add 27.28% | 40,983 | $0.02 |
| Q3 2022 | -13,824 | Reduce 30.04% | 32,200 | $14.81 |
| Q2 2022 | -43,976 | Reduce 48.86% | 46,024 | $27.40 |
| Q1 2022 | +81,300 | Add 934.48% | 90,000 | $37.71 |
| Q4 2021 | +8,700 | New Buy | 8,700 | $62.07 |
| Q3 2019 | -32,100 | Sold Out | 0 | $0.00 |
| Q2 2019 | +32,100 | New Buy | 32,100 | $16.20 |
Renaissance Technologies (RenTech)'s OptimizeRx Corporation Investment FAQs
Renaissance Technologies (RenTech) first purchased OptimizeRx Corporation (OPRX) in Q2 2019, acquiring 32,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held OptimizeRx Corporation (OPRX) for 19 quarters since Q2 2019.
Renaissance Technologies (RenTech)'s largest addition to OptimizeRx Corporation (OPRX) was in Q1 2026, adding 216,856 shares worth $1.36 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 216,856 shares of OptimizeRx Corporation (OPRX), valued at approximately $1.36 M.
As of the Q1 2026 filing, OptimizeRx Corporation (OPRX) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in OptimizeRx Corporation (OPRX) was 216,856 shares, as reported at the end of Q1 2026.